These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16177987

  • 1. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
    Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G.
    Cancer; 2005 Nov 01; 104(9):1968-74. PubMed ID: 16177987
    [Abstract] [Full Text] [Related]

  • 2. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
    Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G.
    Cancer; 2005 Sep 15; 104(6):1281-7. PubMed ID: 16078267
    [Abstract] [Full Text] [Related]

  • 3. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):227-30. PubMed ID: 17278121
    [Abstract] [Full Text] [Related]

  • 4. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
    Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V, Mechinaud F, Millot F, Kalifa C, Chastagner P.
    Cancer; 2005 Dec 15; 104(12):2792-7. PubMed ID: 16265674
    [Abstract] [Full Text] [Related]

  • 5. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
    Packer RJ, Prados M, Phillips P, Nicholson HS, Boyett JM, Goldwein J, Rorke LB, Needle MN, Sutton L, Zimmerman RA, Fitz CR, Vezina LG, Etcubanas E, Wallenberg JC, Reaman G, Wara W.
    Cancer; 1996 May 15; 77(10):2150-6. PubMed ID: 8640684
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.
    López-Aguilar E, Sepúlveda-Vildósola AC, Betanzos-Cabrera Y, Rocha-Moreno YG, Gascón-Lastiri G, Rivera-Márquez H, Wanzke-del-Angel V, Cerecedo-Díaz F, de la Cruz-Yañez H.
    Arch Med Res; 2008 Oct 15; 39(7):655-62. PubMed ID: 18760193
    [Abstract] [Full Text] [Related]

  • 7. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
    Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, Blaney S, Hershon L, Zhou T, Chen Z, Kretschmar C.
    Pediatr Blood Cancer; 2005 Oct 15; 45(5):644-8. PubMed ID: 16110498
    [Abstract] [Full Text] [Related]

  • 8. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK, Kortmann RD, Pietsch T, Emser A.
    Klin Padiatr; 2004 Oct 15; 216(6):331-42. PubMed ID: 15565548
    [Abstract] [Full Text] [Related]

  • 9. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK, Kaatsch P, Kortmann R, Wiestler OD.
    Klin Padiatr; 2000 Oct 15; 212(4):177-84. PubMed ID: 10994547
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
    MacDonald TJ, Arenson EB, Ater J, Sposto R, Bevan HE, Bruner J, Deutsch M, Kurczynski E, Luerssen T, McGuire-Cullen P, O'Brien R, Shah N, Steinbok P, Strain J, Thomson J, Holmes E, Vezina G, Yates A, Phillips P, Packer R.
    Cancer; 2005 Dec 15; 104(12):2862-71. PubMed ID: 16315242
    [Abstract] [Full Text] [Related]

  • 13. The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study.
    Janssens GO, Gidding CE, Van Lindert EJ, Oldenburger FR, Erasmus CE, Schouten-Meeteren AY, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):722-6. PubMed ID: 18990510
    [Abstract] [Full Text] [Related]

  • 14. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R.
    Cancer; 1999 Sep 15; 86(6):1064-9. PubMed ID: 10491535
    [Abstract] [Full Text] [Related]

  • 15. Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.
    Aquino-Parsons C, Hukin J, Green A.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):397-9. PubMed ID: 17009221
    [Abstract] [Full Text] [Related]

  • 16. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 15; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.
    Cancer; 2009 Oct 01; 115(19):4514-23. PubMed ID: 19634161
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A.
    Lung Cancer; 2007 Nov 01; 58(2):238-45. PubMed ID: 17658655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.